Evidence map›Paper›PMID 38019701›Full record

ArticleInfluenza and other respiratory viruses2023

Descriptive epidemiology of SARS-CoV-2 Beta (B.1.351) variant cases in England, December 2020 to June 2022.

Mary A Sinnathamby, Asad Zaidi, Katherine A Twohig, Shirin Aliabadi, Nurin Abdul Aziz, Natalie Groves, Eileen Gallagher, Simon Thelwall, Gavin Dabrera

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Influenza and other respiratory viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary A SinnathambyCOVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.ORCID 0000-0001-6212-4672
Asad ZaidiCOVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.
Katherine A TwohigCOVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.ORCID 0000-0001-9514-0097
Shirin AliabadiCOVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.
Nurin Abdul AzizCOVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.
Natalie GrovesGenomics Public Health Analysis, TARZET Division, Clinical and Emerging Infections Directorate UK Health Security Agency London UK.
Eileen GallagherGenomics Public Health Analysis, TARZET Division, Clinical and Emerging Infections Directorate UK Health Security Agency London UK.
Simon ThelwallCOVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.
Gavin DabreraCOVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.ORCID 0009-0006-9675-9661

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of the SARS-CoV-2 Beta (B.1.351) variant in November 2020 raised concerns of increased transmissibility and severity. We describe the epidemiology of 949 confirmed SARS-CoV-2 Beta variant cases in England, identified between December 2020 and June 2022. Most cases were detected in the first 3 months. A total of 10 deaths (1.1%; 10/949) were identified among all cases and of those with travel information, 38 (4.9%; 38/781) cases with hospital admissions within 14 days of a positive test being detected. 52.9% (413/781) cases were imported. This study reinforces the importance of monitoring of travel-associated cases to inform public health response and reduce transmissibility of new variants.

Indexed as

COVID-19SARS-CoV-2EnglandHumansTravelB.1.351EnglandSARS-CoV-2 Betasecond generation surveillance systemtravelwhole genome sequencing

Identifiers

PMID38019701
PMCPMC10651643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.